Following the July European Court of Justice decision to regulate gene-edited crops as GMOs, a debate over the costs and benefits of CRISPR-Cas9 and other gene editing techniques has raged between activists and scientists. As the GLP reported in July:
…. this ruling will force gene-edited plants to go through a regulatory process that typically costs about $35 million, …. meaning only large companies will be able to afford to walk the regulatory gauntlet, effectively pricing out universities, nonprofits and small companies which are poised in other countries to lead the gene editing revolution. That then tees up the new technology for attacks from European advocacy groups which will undoubtedly then claim that gene editing is yet another new product of ‘Big Ag.’
In this discussion hosted by Canadian news outlet TVO, biotech researchers and science communicators attempt to clear up the confusion around gene editing and explain how it could impact our food supply.
Original video: Agricultural Biotech at Home and Abroad
